Prevention and Control of Rabies in Animals and Humans in Ethiopia

Jemil Alemar Ali
{"title":"Prevention and Control of Rabies in Animals and Humans in Ethiopia","authors":"Jemil Alemar Ali","doi":"10.46718/jbgsr.2022.11.000263","DOIUrl":null,"url":null,"abstract":"Summary Rabies, a viral disease caused bylyssa virus of family Rhabdoviridae. It is a fatal zoonotic disease with worldwide occurrence and endemic in developing countries of Africa and Asia. The disease generally affects all warm-blooded animals, even though it is primarily a disease of dogs in Ethiopia and elsewhere in Africa. More than 95% of human rabies cases are due to bites by infected animals, predominantly from saliva of domestic dogs. Once clinical symptoms appear, it is almost 100% fatal, in which the disease is one of the major public-health burdens in Ethiopia. The country has the second most rabies related deaths in Africa. Although it is entirely preventable, nearly 3000 lives are lost every year in Ethiopia, with high economic burden and Daily Adjusted Life-Years (DALYs). Mass dog vaccination along with prompt administration of post-exposure prophylaxis (PEP) to bite victims, public awareness and ‘One-Health’ approach are successful elements for rabies prevention and control programmes. Low effort of animal rabies control by government and stake holders, lack of finance, limited rabies diagnostic capacity, neglect and lack of coordination and among others are the challenges holding back not to control a century long deadly disease in resource limited African countries like Ethiopia. Thus, this paper provides a brief overview of the varied measures for Rabies prevention and control in animals and humans in Ethiopia. ELISA: Enzyme Linked Immunosorbent Assay; ERIG: Equine Rabies Immunoglobulin; FAT: Fluorescent Antibody Test; GARC: Global Alliance for Rabies Control; HRIG: Human Rabies Immunoglobulin; HDCV: Human Diploid Cell Vaccine; IU: International Unit; MEEREB: Middle East and Central Eastern Europe Rabies Expert Bureau; OIE: World Organization for Animal Health (Organization International des Epizootes); PEP: Post Exposure Prophylaxis; PrEP: Pre-Exposure Prophylaxis; PCECV: Purified Chick Embryo Cell Vaccine; PRP: Partners for Rabies Prevention; RABV: Rabies Virus; RIA: Rabies in Asia Foundation; RIG: Rabies Immunoglobulin; RMCV: Rhesus Monkey Kidney Cell Vaccine; RNA: Ribonucleic Acid; RT-PCR: Reverse Transcription Polymerase Chain Reaction; SEARG: Southern and Eastern Africa Rabies Group; UK: United Kingdom; USD: United States Dollar; UV: Ultra Violet; WHO: World Health Organization because the clinical findings are similar to those of furious and dumb rabies. In acute lead poisoning, the common clinical findings are blindness, convulsions, death within 2 and 4 days after onset, pharyngeal paralysis, dysphagia, weakness and recumbency. 7. Vitamin A deficiency in cattle- occurs in groups of young cattle from 6 months to 18 months of age not receiving adequate carotene intake or vitamin A supplementation and is characterized by blindness in the ocular form and episodes of tremors and convulsions.","PeriodicalId":405266,"journal":{"name":"Open Access Journal of Biogeneric Science and Research","volume":"907 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Journal of Biogeneric Science and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46718/jbgsr.2022.11.000263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Summary Rabies, a viral disease caused bylyssa virus of family Rhabdoviridae. It is a fatal zoonotic disease with worldwide occurrence and endemic in developing countries of Africa and Asia. The disease generally affects all warm-blooded animals, even though it is primarily a disease of dogs in Ethiopia and elsewhere in Africa. More than 95% of human rabies cases are due to bites by infected animals, predominantly from saliva of domestic dogs. Once clinical symptoms appear, it is almost 100% fatal, in which the disease is one of the major public-health burdens in Ethiopia. The country has the second most rabies related deaths in Africa. Although it is entirely preventable, nearly 3000 lives are lost every year in Ethiopia, with high economic burden and Daily Adjusted Life-Years (DALYs). Mass dog vaccination along with prompt administration of post-exposure prophylaxis (PEP) to bite victims, public awareness and ‘One-Health’ approach are successful elements for rabies prevention and control programmes. Low effort of animal rabies control by government and stake holders, lack of finance, limited rabies diagnostic capacity, neglect and lack of coordination and among others are the challenges holding back not to control a century long deadly disease in resource limited African countries like Ethiopia. Thus, this paper provides a brief overview of the varied measures for Rabies prevention and control in animals and humans in Ethiopia. ELISA: Enzyme Linked Immunosorbent Assay; ERIG: Equine Rabies Immunoglobulin; FAT: Fluorescent Antibody Test; GARC: Global Alliance for Rabies Control; HRIG: Human Rabies Immunoglobulin; HDCV: Human Diploid Cell Vaccine; IU: International Unit; MEEREB: Middle East and Central Eastern Europe Rabies Expert Bureau; OIE: World Organization for Animal Health (Organization International des Epizootes); PEP: Post Exposure Prophylaxis; PrEP: Pre-Exposure Prophylaxis; PCECV: Purified Chick Embryo Cell Vaccine; PRP: Partners for Rabies Prevention; RABV: Rabies Virus; RIA: Rabies in Asia Foundation; RIG: Rabies Immunoglobulin; RMCV: Rhesus Monkey Kidney Cell Vaccine; RNA: Ribonucleic Acid; RT-PCR: Reverse Transcription Polymerase Chain Reaction; SEARG: Southern and Eastern Africa Rabies Group; UK: United Kingdom; USD: United States Dollar; UV: Ultra Violet; WHO: World Health Organization because the clinical findings are similar to those of furious and dumb rabies. In acute lead poisoning, the common clinical findings are blindness, convulsions, death within 2 and 4 days after onset, pharyngeal paralysis, dysphagia, weakness and recumbency. 7. Vitamin A deficiency in cattle- occurs in groups of young cattle from 6 months to 18 months of age not receiving adequate carotene intake or vitamin A supplementation and is characterized by blindness in the ocular form and episodes of tremors and convulsions.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚动物和人类狂犬病的预防和控制
狂犬病是一种由狂犬病毒科溶血病毒引起的病毒性疾病。它是一种致命的人畜共患疾病,在世界范围内发生,在非洲和亚洲的发展中国家流行。这种疾病通常影响所有温血动物,尽管它主要是埃塞俄比亚和非洲其他地方的狗的疾病。超过95%的人类狂犬病病例是由受感染动物咬伤所致,主要是由家养狗的唾液咬伤所致。一旦出现临床症状,几乎100%致命,这种疾病是埃塞俄比亚主要的公共卫生负担之一。该国是非洲狂犬病相关死亡人数第二多的国家。尽管这是完全可以预防的,但埃塞俄比亚每年仍有近3000人因此丧生,经济负担沉重,每日调整生命年(DALYs)也很高。大规模犬只疫苗接种以及对咬伤受害者及时进行接触后预防、公众意识和“一个健康”方法是狂犬病预防和控制规划的成功要素。在埃塞俄比亚等资源有限的非洲国家,政府和利益攸关方控制动物狂犬病的努力不足、缺乏资金、狂犬病诊断能力有限、被忽视和缺乏协调等,都是阻碍控制这一长达一个世纪的致命疾病的挑战。因此,本文简要概述了埃塞俄比亚动物和人类预防和控制狂犬病的各种措施。ELISA:酶联免疫吸附试验;ERIG:马狂犬病免疫球蛋白;FAT:荧光抗体试验;GARC:全球狂犬病控制联盟;人狂犬病免疫球蛋白;人二倍体细胞疫苗;IU:国际单位;MEEREB:中东和中东欧狂犬病专家局;世界动物卫生组织(国际兽疫组织);PEP:暴露后预防;PrEP:暴露前预防;纯化鸡胚细胞疫苗;预防狂犬病合作伙伴;狂犬病病毒;RIA:亚洲狂犬病基金会;RIG:狂犬病免疫球蛋白;恒河猴肾细胞疫苗;RNA:核糖核酸;RT-PCR:逆转录聚合酶链反应;南部和东部非洲狂犬病群;UK:联合王国;USD:美元;UV:紫外线;世卫组织:世界卫生组织,因为临床结果与狂怒和哑型狂犬病相似。急性铅中毒的常见临床表现为失明、抽搐、发病后2 ~ 4天内死亡、咽部麻痹、吞咽困难、虚弱和仰卧。7. 牛的维生素A缺乏症——发生在6个月至18个月大的牛群中,没有摄入足够的胡萝卜素或补充维生素A,其特征是眼部失明和震颤和抽搐发作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Dynamics of Covid-19 Cases in Russia Analysis of the Major Gastrointestinal Parasites Community in Yili Horses in Zhaosu of Xinjiang, Western China Prevention and Control of Rabies in Animals and Humans in Ethiopia Debate about foster motherhood Formulation Development of “RUNNY NOSE NAPKIN”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1